Patents by Inventor Jutta Kollet

Jutta Kollet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric antigen receptor specific for tumor cells
    Patent number: 12161705
    Abstract: The present invention is directed to ligand like a chimeric antigen receptor (CAR), comprising an antigen binding domain specific for one or more antigens selected from the group consisting of CLA, CD142, CD73, CD49c, CD66c, CD104, CD318 and TSPAN8; cell populations expressing such CARs and the use of the cell populations for cancer therapy.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: December 10, 2024
    Assignee: Miltenyi Biotec B.V. & Co. KG
    Inventors: Dominik Eckardt, Andreas Bosio, Jutta Kollet, Olaf Hardt, Andrzej Dzionek, Stefan Tomiuk
  • Compositions and Methods for Treating Cancer Expressing CD90 and CD326
    Publication number: 20230183372
    Abstract: The present invention provides a combination comprising a) an antigen binding domain specific for CD90, and b) an antigen binding domain specific for CD326, for use in treatment of human cancer comprising cancerous cells that co-express CD90 and CD326. In one embodiment of the invention the combination comprises a) an immune cell comprising a CAR comprising an antigen binding domain specific for a tag of a first and a second polypeptide, b) said tagged first polypeptide that has an antigen binding domain specific for CD90, and c) said tagged second polypeptide that has an antigen binding domain specific for CD326, wherein the tag of the first polypeptide and the tag of the second polypeptide are identical. In a further embodiment the concentrations used for said first and that second polypeptide are below the activation threshold of said CAR, respectively, but the sum of both concentrations is above the activation threshold of said CAR.
    Type: Application
    Filed: May 19, 2021
    Publication date: June 15, 2023
    Inventors: Christoph Herbel, Dominik Eckardt, Vera Dittmer, Manuel Martinez-Osuna, Jutta Kollet, Thorsten Olaf Hardt, Andreas Bosio
  • CHIMERIC ANTIGEN RECEPTOR SPECIFIC FOR TUMOR CELLS
    Publication number: 20210085769
    Abstract: The present invention is directed to ligand like a chimeric antigen receptor (CAR), comprising an antigen binding domain specific for one or more antigens selected from the group consisting of CLA, CD142, CD73, CD49c, CD66c, CD104, CD318 and TSPAN8; cell populations expressing such CARs and the use of the cell populations for cancer therapy.
    Type: Application
    Filed: November 11, 2020
    Publication date: March 25, 2021
    Applicant: Miltenyi Biotec B.V. & Co. KG
    Inventors: Dominik Eckardt, Andreas Bosio, Jutta Kollet, Olaf Hardt, Andrzej Dzionek, Stefan Tomiuk
  • CHIMERIC ANITGEN RECEPTOR SPECIFIC FOR TUMOR CELLS
    Publication number: 20200282035
    Abstract: The present invention is directed to ligand like a chimeric antigen receptor (CAR), comprising an antigen binding domain specific for one or more antigens selected from the group consisting of CLA, CD142, CD73, CD49c, CD66c, CD104, CD318 and TSPAN8; cell populations expressing such CARs and the use of the cell populations for cancer therapy.
    Type: Application
    Filed: March 30, 2020
    Publication date: September 10, 2020
    Applicant: Miltenyi Biotec B.V. & Co. KG
    Inventors: Dominik Eckardt, Andreas Bosio, Jutta Kollet, Olaf Hardt, Andrzej Dzionek, Stefan Tomiuk
  • Chimeric antigen receptor specific for tumor cells
    Patent number: 10617720
    Abstract: The present invention is directed to ligand like a chimeric antigen receptor (CAR), comprising an antigen binding domain specific for one or more antigens selected from the group consisting of CLA, CD142, CD73, CD49c, CD66c, CD104, CD318 and TSPAN8; cell populations expressing such CARs and the use of the cell populations for cancer therapy.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: April 14, 2020
    Assignee: Miltenyi Biotech, GmbH
    Inventors: Dominik Eckardt, Andreas Bosio, Olaf Hardt, Andrzej Dzionek, Stefan Tomiuk, Jutta Kollet
  • Chimeric antigen receptor specific for tumor cells
    Publication number: 20190209611
    Abstract: The present invention is directed to ligand like a chimeric antigen receptor (CAR), comprising an antigen binding domain specific for one or more antigens selected from the group consisting of CLA, CD142, CD73, CD49c, CD66c, CD104, CD318 and TSPAN8; cell populations expressing such CARs and the use of the cell populations for cancer therapy.
    Type: Application
    Filed: October 17, 2017
    Publication date: July 11, 2019
    Applicant: Miltenyi Biotec GmbH
    Inventors: Dominik Eckardt, Andreas Bosio, Olaf Hardt, Andrzej Dzionek, Stefan Tomiuk, Jutta Kollet